<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Investigating the influence of processing conditions on dissolution and physical stability of solid dispersions with fenofibrate and mesoporous silica</dc:title><dc:creator>Baumgartner,	Ana	(Avtor)
	</dc:creator><dc:creator>Dobaj,	Nina	(Avtor)
	</dc:creator><dc:creator>Planinšek,	Odon	(Avtor)
	</dc:creator><dc:subject>mesoporous silica</dc:subject><dc:subject>amorphous solid dispersion</dc:subject><dc:subject>solvent evaporation method</dc:subject><dc:subject>fenofibrate dissolution</dc:subject><dc:subject>physical stability</dc:subject><dc:description>The study aimed to enhance the solubility of the poorly water-soluble drug, fenofibrate, by loading it onto mesoporous silica, forming amorphous solid dispersions. Solid dispersions with 30% fenofibrate were prepared using the solvent evaporation method with three solvents (ethyl acetate, acetone, and isopropanol) at different temperatures (40 °C, boiling point temperature). Various characteristics, including solid-state properties, particle morphology, and drug release, were evaluated by different methods and compared to a pure drug and a physical mixture of fenofibrate and silica. Results revealed that higher solvent temperatures facilitated complete amorphization and rapid drug release, with solvent choice having a lesser impact. The optimal conditions for preparation were identified as ethyl acetate at boiling point temperature. Solid dispersions with different fenofibrate amounts (20%, 25%, 35%) were prepared under these conditions. All formulations were fully amorphous, and their dissolution profiles were comparable to the formulation with 30% fenofibrate. Stability assessments after 8 weeks at 40 °C and 75% relative humidity indicated that formulations prepared with ethyl acetate and at 40 °C were physically stable. Interestingly, some formulations showed improved dissolution profiles compared to initial tests. In conclusion, mesoporous silica-based solid dispersions effectively improved fenofibrate dissolution and demonstrated good physical stability if prepared under appropriate conditions.</dc:description><dc:date>2024</dc:date><dc:date>2024-04-24 12:01:23</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>155933</dc:identifier><dc:identifier>UDK: 544.351.3:615.45</dc:identifier><dc:identifier>ISSN pri članku: 1999-4923</dc:identifier><dc:identifier>DOI: 10.3390/pharmaceutics16050575</dc:identifier><dc:identifier>COBISS_ID: 193690883</dc:identifier><dc:language>sl</dc:language></metadata>
